Interferon alpha-2b activates natural killer cells that can recognize and destroy cancer cells and has been used for the treatment of patients with gastroenteropancreatic neuroendocrine tumors, melanoma, and kidney cancer. The gene discussed is IFNA2; the disease is neuroendocrine neoplasm.